The present application claims priority from Japanese application JP 2007-304905 filed on Nov. 26, 2007, the content of which is hereby incorporated by reference into this application.
1. Field of the Invention
The present invention relates to a device for sample pretreatment that has a micro-reactor formed on a planar substrate for carrying out a reaction of a microscale sample, a reactor sheet that constitutes the device for sample pretreatment, and a method of sample analysis using the device for sample pretreatment.
2. Description of the Related Art
Demand for a technique which allows high-speed treatment/measurement of a large number of samples in large-scale analysis in the field of genomics and proteomics research of recent years has been increasing. For example, a microarray technique in which a large variety of biomolecules are fixed on a substrate and a high-speed technique for sample pretreatment which uses an enzyme fixed on a substrate have been attracting attention. In these techniques, it is necessary to construct on a substrate in advance a reactor which allows a reaction between a molecule on the substrate and a sample solution added onto the substrate. Since a sample, such as blood, in many cases is obtained in minute amounts in an approximate range of several tens to several hundreds microliters, the capacity of the reactor is also required to be small. However, since an area of a certain size or larger is required for a reaction surface, the reactor necessarily needs to have a thin shape having a thickness of 1 mm or smaller. As a material of the reactor, it is desirable to use a hydrophobic material to which a biological sample is unlikely to attach. However, when a sample, which is an aqueous solution, is introduced into such a hydrophobic micro-reactor, uniform sending of the sample solution inside of the reactor is unlikely to be achieved. Accordingly, bubbles are likely to be formed inside of the reactor. In the case where a molecule to be fixed on the substrate is a biological sample, such as antibody and enzyme, it is highly possible that such a sample loses its original function when it is brought into contact with air and desiccated due to bubble entrainment. Furthermore, attachment of the reactor to the substrate is deteriorated due to bubble entrainment; therefore, it is possible that a sample is lost by leaking out from the reactor during a reaction. For these reasons, bubble entrainment is a serious problem in the above-described techniques.
As a technique for preventing bubble entrainment into a minute structure, for example, Japanese Unexamined Patent Application Publication hei 6-343694 describes a method in which one solution flow is temporarily branched into multiple fine solution flows. However, this technique aims to remove, during solution sending, bubbles which have been already contained in a sample. Accordingly, it cannot prevent bubble formation which is due to the hydrophobicity inside of a thin reactor formed on a planar substrate. Moreover, with the shape of this technique, a reaction between a molecule fixed on a planar substrate and a solution, such as carried out in a microarray experiment, cannot be carried out.
Meanwhile, Japanese Patent Application Publication 2006-189374 discloses a technique in which multiple reactors are connected with each other through a flow path of a fine tube and a solution is moved from one reactor to another reactor by using centrifugal force. In this case, connection with the use of a fine tube is adopted for the purpose of solution sending control and prevention of backward flow. However, it is not for preventing bubble entrainment into a flow path.
An object of the present invention is to solve the problems inherent to the conventional techniques, and to provide a device for sample pretreatment which allows no bubble formation when a sample solution is introduced into the minute and hydrophobic inside of a reactor and a method of sample analysis using the device for sample pretreatment.
A device for sample pretreatment of the present invention includes: a hydrophobic micro-reactor which is constructed on a planar substrate; at both end sides of the reactor, an inflow opening that allows a sample to flow into the reactor and an outlet opening that allows air inside the reactor to escape when the sample is flowing thereinto; and at least at one portion, in which a reactor width is 80% or less of the whole width, between the inflow opening and the outlet opening. The reactor is easily attached onto the planar substrate, and is formed by attaching a sheet that has a groove to be a reactor on a lower surface of the sheet onto the planar substrate.
According to this structure, bubble formation is prevented because of a phenomenon in which a sample solution flows towards a part having a narrow reactor width in a concentrated manner at the time of the sample introduction. A sample supposed to be introduced as a target into the reactor of the present invention is typically a sample having a small volume in an approximate range from several tens to several hundreds microliters.
As the planar substrate, ones can be used are obtained by applying a modification appropriate for fixing, if necessary, to: a membrane made of nitrocellulose, PVDF, or the like; glass; silicon used as a wafer and the like; a resin, such as plastics; metal; and the like. As for a type of modification, poly-L-lysine and aminosilane that allow a biomolecule to be fixed thereon by physical adsorption; functional groups, such as an aldehyde group and an epoxy group, that allow a target molecule to be fixed thereon by covalent bonding; and avidin, Ni-NTA, and the like that allow fixing by using the affinity with a target molecule can be used. In addition, a solid phase composed of a thin layer of a hydrophilic porous matrix, such as polyacrylamide gel and agarose gel, can also be used.
As for a material for a sheet that is placed on the planar substrate to form the reactor, it is necessary to use a material that is attachable to the planar substrate and does not affect the sample. For example, polydimethylsiloxane (PDMS) is a good material because a biological sample hardly adheres to PDMS, and also PDMS is cheap and easily processed.
According to the present invention, it is possible to prevent bubble formation when a sample solution is introduced into the minute and hydrophobic inside of a reactor.
Hereinafter, an embodiment of the present invention will be described.
(1) Formation of a Microscale Reactor by Attaching a Reactor Sheet onto a Substrate
As shown in
(2) Fixing of an Enzyme, an Antibody, or the Like onto a Planar Substrate
As shown in
(3) Addition of a Sample Solution into a Microscale Reactor
As shown in
(4) Reaction Between a Molecule Fixed onto a Substrate and a Sample
As shown in
As shown in
Next, by the use of
The principle of preventing bubble formation involves controlling a direction of solution sending in the reactor. Accordingly, as for the shape, in addition to the reactor 302, an equivalent effect is also observed with a shape, as shown by a reactor 303, in which the width of the whole region near the inflow opening, that is, the left half of the reactor is narrow, and a shape, as shown by a reactor 304, in which regions having narrow widths are located in multiple sites between the inflow opening and the outflow opening. Here, arrows in the drawings indicate directions of solution sending.
The percentage of bubble formation in the case where 40 μL of an aqueous solution was introduced into the reactor 301 by the use of a micropipettor in 3 seconds was 18.3%, while the percentage of bubble formation in the case where an aqueous solution was introduced into the reactor 302 was 5%. This shows that change in the shape of the reactor is effective for preventing bubble formation.
Using
The reactor sheet is a PDMS sheet having a size of 35 mm in length×85 mm in width×2 mm in thickness, and having six grooves, which serve as a reactor, formed thereon at 3 mm intervals. The groove has a structure in which two circles having a diameter of 8 mm are connected by a flow path having a width of 3.5 mm and a length of 3 mm, and the depth of the groove is 0.3 mm. The capacity of the reactor is 40 μl. At both ends of the reactor, an inflow opening and an outflow opening each of which has a diameter of 1 mm are provided for injection of a sample into the inside of the reactor.
The vibratory agitation unit is composed of: a holder 401 that holds a device for sample pretreatment constituted by attaching tightly a planar substrate and the reactor sheet; and a vibratory unit 404 having a vibration motor 405. The holder 401 is composed of a lower holder 402 and an upper holder 403. The upper holder 403 has a frame-like shape and an opening part, and while the upper holder 403 holds the device for sample pretreatment at the frame part, it can access the inflow opening of the reactor formed in the device for sample pretreatment through the opening part.
Fixing of Trypsin onto the Planar Substrate
In the present experiment, ProteoChip (Type A, Proteogen) was used as the planar substrate. Proteochip is a protein chip in which a protein binding agent “ProLinker,” which is a kind of calyx crown derivative, onto a slide glass (26 mm in length×76 mm in width). Proteochip allows fixing of a protein onto its surface by an interaction with ProLinker.
The reactor sheet was attached onto Proteochip 201, and they were fixed with each other by the holders 402 and 403. Trypsin (T8802, SIGMA) was prepared at 1 mg/mL using PBS (pH 7.4), and injected into the inside of the reactor through the inflow opening. The inflow opening was sealed by attaching a seal, and the Proteochip 201 was left at rest at 4° C. overnight for fixing of trypsin.
Next, after the reactor sheet was detached from the ProteoChip 201 and put into a washing container 209, washing operation by 10 minute-shaking with the addition of PBS (pH 7.4) was repeated twice. Next, the ProteoChip 201 was rinsed with 10 mM Tris-HCl (pH 8.0) twice, and then residual water droplets on the ProteoChip 201 were removed by the use of a filter paper.
BSA (A9647, SIGMA) was prepared at 1 mg/mL using a denaturation buffer (200 mM Tris-HCl containing 6M guanidine chloride and 2.5 mM EDTA, pH 8.5). One microliter of a reducing solution (sterilized water containing 60 mg/mL DTT) was added to 1 mL of the protein solution. After nitrogen gas was gently blown onto the surface of the solution for 30 seconds, the solution was left at rest at 37° C. for 3 hours so as to carry out denaturation and reduction treatment of the protein. After the reaction, the solution temperature was lowered by placing the solution on ice for 5 minutes, and 20 μL of an alkylation solution (a denaturation buffer containing 50 mg/mL iodoacetamide) was added thereto. After nitrogen gas was gently blown onto the surface of the solution for 30 seconds, the solution was left at rest at room temperature under a light shielding condition for 1 hour so as to carry out alkylation of a cysteine side chain after reduction. Lastly, dialysis in 200 ml of a reaction buffer (Tris-HCl, pH 8.5) at 4° C. for 2 hours was repeated three times so as to remove guanidine chloride in the solution.
The reactor sheet 202 was attached onto the planar substrate on which trypsin had been fixed and they were fixed with each other by the use of the holders 402 and 403 of the vibratory agitation unit. Thereafter, BSA which had been subjected to reduction and alkylation and prepared at 0.2 mg/mL was injected into the inside of the reactor. The vibratory unit 404 was set, and then the planar substrate was subjected to 30 minute-shaking at 37° C. so as to carry out a digestion reaction.
The digested BSA which had been collected was subjected to reverse-phase HPLC analysis, and digestion was confirmed by observing a reduction of a peak which correspond undigested BSA. Measurement conditions are described as follows.
Column: CAPCELLPAK C18 MG (2 mm in inner diameter×75 mm, 3 μm particle diameter, SHISEIDO)
Mobile phase A solution: 2% acetonitrile containing 0.1% TFA
Mobile phase B solution: 98% acetonitrile containing 0.1% TFA
Gradient: After solution sending at a percentage of solution A of 100% for 5 minutes after the initiation of the measurement, linear gradient was performed in which the percentage of solution A was reduced from 100% to 40% (the percentage of solution B was increased from 0% to 60%) over the period from the 5-minutes time point to the time point 60 minutes after the initiation of the measurement.
Flow rate: 0.2 mL/minute
Detection: absorbance at an ultraviolet region (214 nm)
The result of HPLC analysis in the case where a reactor having the shape illustrated as 302 in
On the other hand, in the case where a reactor having the shape illustrated as 301 in
The present invention can be used for a reaction in a microarray experiment and a pretreatment, such as condensation of a certain molecule and enzymatic treatment, for biological molecular analysis.
Number | Date | Country | Kind |
---|---|---|---|
2007-304905 | Nov 2007 | JP | national |